Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Generic substitution.

Literature DB >> 21988164

Generic substitution.

John Posner¹, John P Griffin.

Abstract

Mesh：

Substances：
Drugs, Generic

Year: 2011 PMID： 21988164 PMCID： PMC3243006 DOI： 10.1111/j.1365-2125.2011.03920.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Patient perceptions of generic medicines: a mixed-methods study.

Authors: Suzanne Dunne; Bill Shannon; Colum Dunne; Walter Cullen
Journal: Patient Date: 2014 Impact factor: 3.883

2. Generic substitution for prescribed brand medicines in Ethiopia: knowledge, attitude and practice among pharmacy professionals in community drug retail outlets.

Authors: Sintayehu Alemu; Natnael Tadesse; Tidenek Mulugeta; Desta Assefa
Journal: BMC Health Serv Res Date: 2022-07-19 Impact factor: 2.908

3. Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.

Authors: Luca Degli Esposti; Diego Sangiorgi; Stefano Buda; Ezio Degli Esposti; Francesco Scaglione
Journal: BMJ Open Date: 2016-11-02 Impact factor: 2.692

4. The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.

Authors: Heather C Worthington; Lucy Cheng; Sumit R Majumdar; Steven G Morgan; Colette B Raymond; Stephen B Soumerai; Michael R Law
Journal: Implement Sci Date: 2017-11-25 Impact factor: 7.327

Generic substitution.

1. Patient perceptions of generic medicines: a mixed-methods study.

2. Generic substitution for prescribed brand medicines in Ethiopia: knowledge, attitude and practice among pharmacy professionals in community drug retail outlets.

3. Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.

4. The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.

5. Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review.

6. Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?

7. Institutional framework for integrated Pharmaceutical Benefits Management: results from a systematic review.

8. Safety and efficiency of a new generic package labelling: a before and after study in a simulated setting.

9. Irrational Use of Medicines-A Summary of Key Concepts.